TheraIndx Lifesciences Pvt.Ltd.
Dhanalakshmi Sivanandhan is currently the Chief Scientific Officer at TheraIndx Lifesciences Pvt.Ltd. Having held various roles in prestigious organizations such as Vice President at Jubilant Therapeutics Inc, Director at Jubilant Biosys, and Group Leader at Jubilant Biosys Ltd, Dhanalakshmi has a wealth of experience in the field of life sciences. With a Ph.D. in Oncology and Cancer Biology from Jawaharlal Nehru Vishvavidyalaya, as well as M.Sc in Genetics from the University of Madras and a B.Sc in Life Sciences from Avinashilingam Institute for Home Science and Higher Education for Women, Dhanalakshmi's educational background complements their successful career trajectory.
This person is not in any teams
TheraIndx Lifesciences Pvt.Ltd.
Incorporated in 2014, TheraIndx offers partially or fully integrated drug discovery services across a wide spectrum, covering hit identification, hit to lead, lead optimization and preclinical development. Our multidisciplinary expertise spans across In Vitro ADMET, In Vivo pharmacokinetics, assay development & screening , modelling and simulation, In Vivo pharmacology specialising in advanced animal models with biomarkers, toxicology, microbiology, molecular biology, cell biology, immunology, histopathology, synthetic & medicinal chemistry and computational chemistry. We are one of the fastest growing preclinical CROs in India, catering to a clientele spanning across 5 continents. We take pride in our passion and capabilities to deliver world class preclinical research. At TheraIndx, we value research. At the heart of our business lies our strength for consulting. We understand the challenges faced by a drug discovery team. We, therefore, take utmost care to consult, hand hold & suggest the best possible way to success.